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ABSTRACT
Background Many patients visit primary care clinics 
with a complaint of cough. General practitioners (GPs) 
developed a list of the causative diseases of cough that 
can produce a patient’s symptoms and signs. Then, the 
patients’ medical histories were evaluated to determine 
whether the diagnosis of cough variant asthma (CVA) or 
post-infectious cough (PIC) could have been predicted.
Methods We retrospectively investigated 195 outpa-
tients with a complaint of cough. Medical histories of 
“recurrent episodes of prolonged cough” and “upper 
respiratory infection” were obtained during the initial 
visit. The accuracy of medical histories in predicting 
CVA and PIC was calculated on the area under the 
curve (AUC).
Results Among eligible patients with cough, PIC was 
diagnosed in 99 patients (50.8%), CVA in 40 patients 
(20.5%), upper airway cough syndrome in 28 patients 
(14.4%), and chronic obstructive pulmonary disease 
in 11 patients (5.6%). Among the patients with CVA 
and those with PIC, 93% and 12%, respectively, had a 
history of recurrent episodes of prolonged cough. For 
the diagnosis of CVA, having a history of recurrent epi-
sodes of prolonged cough showed a moderately accurate 
AUC (0.76, 95% CI: 0.71–0.82). On the other hand, for 
the diagnosis of PIC, having no history of recurrent 
episodes of prolonged cough also showed a moderately 
accurate AUC (0.87, 95% CI: 0.82–0.92).
Conclusion The medical history of recurrent episodes 
of prolonged cough is useful for the prediction of CVA 
as well as PIC.
Key words cough variant asthma; post-infectious 
cough; prolonged cough; recurrent episodes
A cough is the most common complaint when patients 
visit their primary care physician, accounting for around 
8% of all consultations.1, 2
In most cases, it is difficult to diagnose the cause 
of the cough. The first step in making a differential 
diagnosis of the cough is to confirm the duration of the 
cough.3–6 Generally, the classification of cough based on 
duration is as follows: acute cough, within 3 weeks of 
onset; sub-acute cough, from 3 to 8 weeks; and chronic 
cough, more than 8 weeks. This classification system is 
a useful tool for narrowing down the potential causes of 
cough.3–6
In adults, causes of acute cough include acute 
upper respiratory infection, acute rhinosinusitis, and 
allergic rhinitis.7 Post-infectious cough (PIC), which is 
defined as a self-limiting cough that persists after viral 
or virus-like infections, is the most common etiology of 
subacute cough.8, 9 Approximately 12%–48% of adult 
patients with subacute cough have PIC.8, 10
Chronic cough is caused by cough variant asthma 
(CVA), upper airway cough syndrome (UACS), and 
gastro-esophageal reflux disease (GERD).11 In Japan, 
CVA is common among diseases that cause of subacute 
and chronic cough.12 The only symptom of CVA is 
cough with no wheezing or dyspnea, which is defined 
as a subtype of asthma that manifests only as a cough. 
In CVA, respiratory function tests are almost normal; 
airway hyperreactivity is mildly increased; and bron-
chodilator (β2-agonist) is effective.6, 13 In adults, CVA 
evolves into typical asthma in 30%–40% of cases, but 
the rate of transition to typical asthma is reduced by 
using inhaled steroids at the time of early diagnosis.14, 15 
Therefore, accurate diagnosis and early therapeutic 
intervention are important for improving treatment ef-
ficacy and the resolution of symptoms of cough.
General practitioners can generally diagnose 
patients accurately based on their pattern of symptoms, 
response to medications, and family history. There is 
recent evidence that clinicians can make an accurate 
diagnosis of the cause of cough for most patients by 
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using their medical history alone.16 Tomita and col-
leagues reported that patients with a high probability of 
asthma were those with nocturnal cough/wheezing and/
or recurrent episodes of cough/wheezing.17 The medi-
cal history often provides important initial clues about 
patients with subacute or chronic cough. According to 
a diagnostic algorithm for the approach to adults with 
cough, all patients should be questioned about the use 
of angiotensin-converting enzyme (ACE) inhibitors and 
the presence of an upper respiratory tract infection at 
the onset of coughing.18 The aim of this study was to 
investigate the utility of typical histories of “recurrent 
episodes of prolonged cough” and “upper respiratory 
infection” as diagnostic indicators of causes of cough in 
a primary care setting.
MATERIALS AND METHODS
Patient population
The subjects were 230 consecutive patients (aged 
18–91 years) with a chief complaint of cough who were 
referred to our clinic as outpatients between January 
2012 and December 2019. We first performed a plain 
chest X-ray test, blood test, spirometry, sputum eosino-
philia, and chest and sinus computerized tomography 
as needed. Respiratory infections, such as pneumonia, 
tuberculosis, and nontuberculous mycobacteriosis, and 
other pulmonary diseases, including lung cancer, meta-
static lung tumor, rheumatic lung, malignant lymphoma, 
and heart failure, were excluded from this study. Cases 
of bronchial asthma with wheezing were also excluded 
from this study.
Medical records of patients who met the inclusion 
criteria were investigated. These records included the 
medical history, smoking history, presence or absence 
of upper respiratory tract infection, atopic diseases, 
recurrent episodes of prolonged cough, total duration of 
cough, characteristics of cough and sputum, postnasal 
drip, heartburn, medication with an ACE inhibitor, 
previous visits to other clinics, and previous medical 
treatment. Regarding the history of prolonged cough, 
we asked questions such as, “Have you ever had a pro-
longed cough similar to this episode?”
This study was conducted in accordance with 
the Declaration of Helsinki and with the approval of 
the Tottori Prefecture Medical Association Ethics 
Committee (accession number: 2020-01). Written 
informed consent was obtained from all subjects.
Definition of acute/subacute/chronic cough
Current cough was divided into subtypes. Acute 
cough was defined as cough lasting less than 3 weeks; 
subacute cough was defined as cough lasting between 3 
and 8 weeks; and chronic cough was defined as cough 
lasting for more than 8 weeks.
Diagnosis of causative diseases
In our approach to diagnosing causative diseases, we 
followed the American College of Chest Physicians 
Guidelines for the management of cough.19
CVA was diagnosed in patients who experienced a 
cough without wheezing for more than 3 weeks but did 
not have wheezing on auscultation. A sputum eosinophil 
test, respiratory tract reversibility test, and fractional 
exhaled nitric oxide measurement, which was measured 
using NIOX VERO® (Aerocrine, Sweden) with a cutoff 
of 30 ppb,20 were evaluated as additional diagnostic 
tools. Based on these examinations, patients with sus-
pected CVA were treated with long-acting β2-agonist 
for 1–2 weeks and were observed for signs of improved 
cough. If improvement was observed, a treatment with 
an inhaled corticosteroid/long-acting β2-agonist (ICS/
LABA) combination was started. Diagnosis of CVA 
was confirmed after the patient presented with a com-
plete release of cough.
PIC was identified as a continuous cough after 
experiencing an upper respiratory tract infection, and a 
final diagnosis was performed if the administration of 
cough suppressants, histamine H1 antagonist, and/or 
Chinese herbal medicine21 effectively improved cough 
at a follow-up of 1–2 weeks.
Upper airway cough syndrome (UACS) was 
defined as cough with nasal blockage or nasal discharge 
(anterior or posterior nasal drip) and either facial pain/
pressure or reduction/loss of smell.22
Esophageal reflux disease was identified if there 
was heartburn and/or regurgitation at least one day per 
week for the past 3 months.23
Atopic cough was diagnosed following the diag-
nostic criteria for general clinical settings: (1) dry cough 
for at least 3 weeks without wheezing or dyspnea, (2) 
no response to bronchodilator therapy, (3) one or more 
findings suggesting an atopic predisposition or induced 
sputum eosinophilia, and (4) relief of cough with hista-
mine H1 antagonists and/or steroids.24 Atopy was also 
defined as a self-reported allergy to pollens, animals, or 
food.
To reach an accurate diagnosis in situations where 
an empirical treatment of PIC or UACS did not improve 
symptoms and CVA was strongly suspected, an inhaled 
corticosteroid (ICS) treatment was performed.
Only cases for which there was a total resolution 
of cough after a follow-up period of 3 months or more 
were examined in this study. We thoroughly inquired 
about the symptoms by phone or other means for cases 
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that did not return to the clinic for a 3-month follow-
up. After confirmation that the cough had resolved, the 
etiologic treatment was judged to be effective, so a final 
diagnosis was made.
Statistical analysis
One-way analysis of variance (ANOVA) was used to 
determine whether there were any statistically signifi-
cant differences in the continuous data among groups. 
A post-hoc analysis was performed using Scheffé’s test. 
Differences in categorical variables between clusters 
were statistically assessed using Fisher’s exact test, and 
the Benjamini–Hockberg procedure was performed to 
correct for multiple comparisons.25
Next, the accuracy of medical histories in predict-
ing PIC and CVA was calculated in terms of sensitivity 
and specificity. Positive likelihood hood ratios (LR+) 
and negative likelihood ratios (LR−) were the primary 
measures of diagnostic accuracy. An LR+ greater than 
10 (an estimated shift in probability of at least 45%) is 
strong evidence to rule in a disease, whereas an LR+ 
between 5 and 10 is moderate (estimated shift of at 
least 30%) and between 2 and 5 is weak (estimated 
shift 15%).26, 27 A plot of specific receiver operating 
characteristic (ROC) curves was used as a graphic 
presentation of the relationship between both sensitivity 
and specificity; it helped to decide the optimal model. 
An area under the curve (AUC) of more than 0.9 was 
defined as high accuracy, between 0.9 and 0.7 as moder-
ate accuracy, and less than 0.7 as low accuracy.28
For all statistical tests, the significance level was 
set at 0.05. Analyses were conducted using R statistical 
software (version 3.5.2; R Foundation for Statistical 
Computing Vienna, Austria).
RESULTS
Among the 230 patients with cough who visited our 
clinic between January 2012 and December 2019, 16 
presented with cases of organic diseases (8 cases of 
pneumonia, 2 of nontuberculous mycobacteriosis, 1 of 
lung cancer, 1 of metastatic lung tumor, 1 of sequela of 
pulmonary tuberculosis, 1 of rheumatic lung, 1 of ma-
lignant lymphoma, and 1 of heart failure); 2 presented 
with bronchial asthma; and 17 were undiagnosed cases, 
which were subsequently excluded from this study. 
Among these were 82 males and 113 females with 
an average age of 49.7 ± 18.2 years old; 21.5% were 
smokers. Cough was classified as acute in 29 patients, 
subacute in 114 and chronic in 55. The total duration 
of cough was 50.3 days on average (17.0 days for acute 
cough, 36.6 days for subacute cough, and 99.3 days for 
chronic cough). Out of the patients who complained of 
cough, 15% had a history of treatment at other medical 
institutions. Among those who had been treated at other 
medical institutions, no one was being treated with 
inhaled steroids at the time of their visit to our clinic.
The causes of cough in 195 outpatients are listed in 
Table 1. PIC was the most common etiology of cough in 
50.8% of cases, followed by CVA in 20.5%, and UACS 
in 14.4%. When the distributions of duration were 
analyzed, PIC was the cause of acute cough in 75.9% of 
patients, subacute cough in 63.2%, and chronic cough in 
9.6%. On the other hand, CVA was the second cause of 
subacute cough in 23.7% and chronic cough in 25.0% of 
cases. Table 2 provides details on differences in charac-
teristics between PIC and CVA. Compared with CVA, 
patients with PIC had a more recent and shorter duration 
of cough, shorter treatment period, lower prevalence 
of having a history of recurrent episode of prolonged 
cough, higher prevalence of preceding upper respiratory 
Table 1. Diagnosis classified by the duration of cough (n = 195)
Diagnosis Total (n = 195) Acute (n = 29) Subacute (n = 114) Chronic (n = 52)
n (%) n (%) n (%) n (%)
PIC 99 (50.8) 22 (75.9) 72 (63.2) 5 (9.6)
CVA 40 (20.5) 0 (0.0) 27 (23.7) 13 (25.0)
UACS 28 (14.4) 6 (20.7) 9 (7.9) 13 (25.0)
CB/COPD 11 (5.6) 1 (3.0) 2 (1.8) 8 (15.4)
AC 7 (3.6) 0 (0.0) 3 (2.6) 4 (7.7)
GERD 6 (3.1) 0 (0.0) 0 (0.0) 6 (11.5)
OSAS 2 (1.0) 0 (0.0) 0 (0.0) 2 (3.8)
ACE-induced 2 (1.0) 0 (0.0) 1 (0.9) 1 (1.9)
AC, Atopic cough; ACE, Angiotensin-converting enzyme inhibitor; CB/COPD, Chronic bronchitis/Chronic obstructive pulmonary 
disease; CVA, Cough variant asthma; GERD, Gastro-esophageal reflex disease; OSAS, Obstructive sleep apnea syndrome; PIC, Post-
infectious cough; UACS, Upper airway cough syndrome.
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infection, and lower atopic predisposition. There was 
no significant difference between PIC and CVA in the 
duration of cough before the visit to our clinic.
As AUC is an effective way to summarize the 
overall diagnostic accuracy of the test, we analyzed 
AUC to predict PIC and CVA while using the medical 
history as a clue (Fig. 1). In patients with CVA, having a 
history of recurrent episode of prolonged cough showed 
93% sensitivity and 60% specificity [AUC: 0.76, 95% CI 
(0.71–0.82)] (Fig. 1A). Additionally, the positive likeli-
hood ratio was 2.3, and the negative likelihood ratio was 
0.16. In patients with PIC, having no history of recurrent 
episode of prolonged cough showed an 86% sensitivity 
and 89% specificity [AUC: 0.87, 95% CI (0.82–0.92)] 
(Fig. 1B). The positive likelihood ratio was 7.8, and the 
negative likelihood ratio was 0.16. In patients with PIC, 
having a history of “upper respiratory infection” showed 
a 100% sensitivity and 37% specificity [AUC: 0.67, 
95% CI (0.63–0.73)] (Fig. 1C). The positive likelihood 
ratio was 1.6. In patients with CVA, having no history 
of upper respiratory infection showed a 38% sensitivity 
and 86% specificity [AUC: 0.62, 95% CI (0.54–0.70)] 
(Fig. 1D). The positive likelihood ratio was 2.7, and the 
negative likelihood ratio was 0.72.
DISCUSSION
It is a common consensus in many previous studies 
that respiratory tract infection and PIC accounts for the 
highest proportion of acute cough cases10, 29–31 and is a 
minor cause of chronic cough.10, 12, 30, 32 In our study, 
PIC was the specified cause of acute cough and chronic 
cough, occurring with 75.8% and 8.0% prevalence, 
respectively, in patients with cough.
The prevalence of causes of subacute cough 
depends on the sample size and specialty of the institu-
tion.8, 10, 12, 31 Multicenter studies have demonstrated 
that the prevalence of CVA (46.9%–58.3%) was higher 
than that of PIC (11.6%–12.2%).10, 12 On the other hand, 
Kwon and colleagues demonstrated that the prevalence 
of CVA (15.8%) was lower than that of PIC (48.4%) in 
single center studies.8 Our results, demonstrating a high 
prevalence of PIC in diseases causing subacute cough, 
were in concordance with Kwon’s study. We speculated 
that the main reason for this might be that our enrolled 
patients had no history of treatment with inhaled 
steroids in other institutions, as this was a similar 
characteristic in Kwon’s patients. In situations where an 
empirical treatment of PIC did not improve symptoms 
and CVA was strongly suspected, a steroid treatment 
was performed. This procedure allowed us to accurately 
diagnose PIC and CVA.
In primary care clinics, medical history is the 
most useful tool in clinical reasoning for the diagnosis 
of diseases. In this study, we showed the utility of 
some medical histories, such as “recurrent episodes of 
prolonged cough” and “upper respiratory infection” 
as a diagnostic approach to identifying the causes of a 
cough. In patients with asthma, Tomita and colleagues17 
demonstrated that recurrent episodes of symptoms of 
cough and/or wheezing is a useful indicator for predict-
ing asthma, with an LR+ of 3.22 and LR− of 1.28. Our 
study revealed that the recurrent episodes of prolonged 
Table 2. Clinical characteristics of total patients (n = 195)
PIC CVA Others P-value
Number of patients 99 40 56
Age, years 46.5 ± 17.6* 51.8 ± 17.5 53.8 ± 183 0.04
% Female 65.7%* 62.5% 41.1% 0.01
% Smoker 18.2% 15.0%* 32.1% 0.08
Duration of cough, days 32.5 ± 13.5** 50.8 ± 2 1.1** 81.9 ± 79.2 < 0.01***
Duration of cough before the visit, days 17.8 ± 10.0** 23.7 ± 17.3** 49.7 ± 71.6 < 0.01
Period of cough treatment, days 14.7 ± 9.0** 26.5 ± 12.5* 32.2 ± 21.1 < 0.01***
% Atopy 37.4% 87.5%** 44.6% < 0.01***
% Recurrent episodes of prolonged cough 12.1%** 92.5% 85.7% < 0.01***
% Upper respiratory infection 100.0%** 62.5% 64.3% < 0.01***
% Previous treatment 16.8%** 11.4%** 22.0% < 0.01***
CVA, cough variant asthma; PIC, post-infection cough. Others include AC, ACE induced cough, CB/COPD, GERD, OSAS and 
UACS. *P < 0.05 vs. others, **P < 0.01 vs. others, and ***P < 0.01 between PIC and CVA. Differences in numerical variables between 
groups were analyzed by using one-way analysis of variance (ANOVA) and Scheffe's post-hoc test. Differences in categorical variables 
between groups were statistically tested by using Fisher's exact test, and correction for multiple comparisons was performed using the 
Benjamini–Hochberg procedure.25
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cough noted in the medical history are useful in diag-
nosing the causative diseases of a cough. Patients with 
CVA were more likely to have a history of recurrent 
episodes of prolonged cough (LR+ of 2.3); this result 
supports Tomita’s research. In addition, patients with 
PIC were more likely to have no history of recurrent 
episodes of prolonged cough (LR+ of 7.8), which is use-
ful to distinguish PIC from non-PIC.
There are some limitations to this study. First, a 
relatively small number of patients with cough were 
examined at a single center. Although the sample size 
was small, the homogeneity of subjects was preserved, 
which eliminated any assumption bias. However, a 
larger study without selection bias is still needed. 
Another limitation is that we did not assess all potential 
causes of cough. Some studies reported that chronic 
cough may have overlapping diseases among asthma, 
UACS, and GERD, alone or in combination,33 as well as 
overlapping etiologies, including smoking, asthma, and 
allergic rhinitis.34 Since it was reported that eosinophilic 
airway inflammation is common in subacute cough 
following acute upper respiratory tract infection,35 there 
is a possibility of overlapping diagnoses with CVA or 
PIC.
In conclusion, 70% of causative diseases of cough 
were CVA or PIC in a primary care setting. Medical 
histories of “recurrent episodes of prolonged cough” 
and “upper respiratory infections” were useful clues 
for predicting CVA and PIC, respectively. However, ap-
proximately one-third of patients in primary care with 
symptoms that are compatible with asthma and normal 
lung function exhibit airway hyperresponsiveness to 
methacholine36; thus, the limitations of simple spirom-
etry for the diagnosis of asthma must be considered. 
In the future, the timing of a hospital consultation for 
cough patients, who were resistant to treatments includ-
ing ICS, should be studied.
The authors declare no conflict of interest.
Fig. 1. The ROC curve for a diagnostic test of a patient with a medical history of (A) “recurrent episode of prolonged cough” and its 
discrimination between CVA and non-CVA; (B) “no recurrent episode of prolonged cough” and its discrimination between PIC and 
non-PIC; (C) “upper respiratory infection” and its discrimination between PIC and non-PIC; and (D) “no upper respiratory infection” 
and its discrimination between CVA and non-CVA.
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